Also listed on Onkosxcel Therapeutics, LLC, an earlier holder on the record. The recorded assignments below show how it moved.
Collateral for a security interest recorded Sep 11, 2024 (Oaktree Fund Administration, LLC).
Term ends Jul 4, 2039 · High confidence
20-year base term ends Jan 9, 2038
Held by Bioxcel Therapeutics, Inc.
Filed Jul 8, 2019 as application 16/476,420 · Granted Mar 28, 2023
Base term plus 541 days of patent term adjustment (USPTO delay)
Today
2018
2039
Clock starts
Jan 9, 2018
Jan 9, 2018
Term ends
Jul 4, 2039
Jul 4, 2039
Granted
Mar 28, 2023
Mar 28, 2023
base term
patent term adjustment
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
541
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 541 days past its 20-year base term on prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 9, 2018, when application PCT/US2018/012876, the earliest non-provisional in its chain, was filed (this one was filed Jul 8, 2019) | Jan 9, 2038 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +541 days, USPTO patent term adjustment record | Jul 4, 2039 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jul 4, 2039 | High confidence |
This family
| Application PCT/US2018/012876 | PCT application no patent term | no patent term |
| US 11,613,785 | this patent Jul 2039 | Jul 2039 |
| Application 18/157,717 | Abandoned not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 8, 2019 Reel 49689, frame 674 | Nandabalan, Krishnan; Rastelli, Luca | Bioxcel Therapeutics, Inc. | Assignment of Assignor's Interest |
| Sep 11, 2024 Reel 68938, frame 906 | Bioxcel Therapeutics, Inc. | Oaktree Fund Administration, LLC | Security Interest |
| Nov 22, 2024 Reel 69377, frame 185 | Onkosxcel Therapeutics, LLC | Oaktree Fund Administration, LLC | Security Interest |
| Aug 31, 2026 Reel 75851, frame 89 | Bioxcel Therapeutics, Inc.; Onkosxcel Therapeutics, LLC | Oaktree Fund Administration, LLC | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Jul 2039
Term ends Jul 4, 2039. Maintenance fees still fall due before then
Note
The 541 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
0
later US patents cite this one
That is below the median of utility patents granted in 2023 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.